AlphaYou
Overview
Key stats
Fundamentals Sep 9- Open
- $278.54
- 52-wk high
- $303.31
- High
- $280.75
- 52-wk low
- $144.26
- Low
- $275.00
- Prev close
- $280.76
- Mkt cap
- $13.52B
- Volume
- 781.2K
- Fwd P/E
- 23.4x
- Beta
- 1.41
- P/S
- 3.4x
- P/B
- 4.8x
- Profit margin
- -6.0%
- Op margin
- +15.1%
- ROE
- -7.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 11.0% above what analysts expected.
Earnings per share
$2.72 expected
What the street expects next
EPS expected
$2.92 to $3.00
Revenue expected
9 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.00B | $994.2M | $995.8M | $1.00B |
| Cost of what it sold | $666.1M | $686.4M | $716.5M | $640.7M |
| Gross profit | $338.8M | $307.9M | $279.3M | $363.4M |
| What it spent | ||||
| Sales and admin | $177.6M | $187.6M | $159.4M | $228.9M |
| Other operating costs | $27.4M | — | — | $14.6M |
| Total operating expenses | $205.0M | $187.6M | $159.4M | $243.5M |
| What was left | ||||
| Operating profit | $133.8M | $120.2M | $119.9M | $119.9M |
| Interest on debt | $25.4M | $23.8M | $26.7M | $30.3M |
| Profit before tax | $87.2M | -$294.1M | -$29.9M | $53.2M |
| Tax | $31.6M | -$17.8M | -$15.1M | $53.9M |
| Net profit | $54.4M | -$276.6M | -$14.8M | -$1.5M |
| EBITDA | $197.8M | -$192.0M | $64.0M | $150.8M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Charles River Labs stock trades near TD Cowen target after recent gains
Leans bullishSep 9Charles River Laboratories International (CRL) Could Be 8% Undervalued After Endosafe Automation Ramp
Leans bullishSep 8One investor controls millions of Charles River (NYSE: CRL) shares
NeutralSep 8Charles River Launches Automated Endosafe Manufacturing Suite
BullishSep 8Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
BullishSep 8Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors
BearishSep 8Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite
BullishSep 8Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors
Leans bearishSep 4
Macro
10 macro signals shaping CRL right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results